Maxxon, Globe Med Tech complete final design of ReVax Safety Syringe

By Lisa Kerner

Charlotte, N.C., June 15 - Maxxon, Inc. said results of Globe Med Tech's user/lab study has resulted in the final design of the Maxxon 3cc Vacuum Operated Retractable Safety Syringe (ReVac) plunger.

Globe Med Tech has manufactured the 5,000 piece sample for application to the Food and Drug Administration and customer evaluation prior to seeking FDA 510k registration, according to a company news release.

All biocompatibility and clinical testing of the samples is expected to be completed in two to three months.

"It may seem like a small step, but it's actually a giant move forward for us, due to the significance of clinical test for FDA registration, which is why product development takes years to accomplish from patent concept to real functional sample that meet design, FDA and marketing criteria," Maxxon chief technology officer Andy Hu said in the release.

Located in Mount Pleasant, S.C., Maxxon produces safety-engineered medical devices including the ReVac Safety Syringe, Auto Retractable Safety Scalpel with Permanent Lock and the Auto Retractable Safety IV Catheter.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.